Canopy Growth (CGC) vs Alpha Teknova (TKNO)
Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Oct 8, 2026.
Summary
Alpha Teknova (TKNO) has outperformed Canopy Growth (CGC) over the past year, gaining 66.2% versus a loss of 39.6%. Over five years, TKNO leads with a -62.3% price change compared with -99.3% for CGC. Alpha Teknova is the larger company by market cap ($467.6 million vs $393.8 million), about 1.2 times the size.
Summary generated from market data by MetaCap's automated system. Methodology
Relative performance
Percent change in share price from the first common trading day shown; excludes dividends.
Head-to-head
| Metric | CGC | TKNO |
|---|---|---|
| Share price | $0.8765 | $8.71 |
| Market cap | $393.81M | $467.62M |
| 1-day change | -1.59% | -0.46% |
| YTD return | -23.11% | +129.21% |
| 1-year return | -39.55% | +66.22% |
| 5-year return | -99.34% | -62.29% |
| EPS (TTM) | $-0.45 | $-0.31 |
| Dividend yield | 0.00% | 0.00% |
| Annual dividend | $0.00 | $0.00 |
| 52-week high | $2.38 | $9.48 |
| 52-week low | $0.844 | $1.91 |
| Distance from 52-week high | -63.17% | -8.12% |
| Analyst consensus | none | strong_buy |
| Avg. price target upside | +35.77% | +3.33% |
| Average volume | 2.77M | 230.41K |
| Shares outstanding | 423.04M | 53.69M |
| Employees | 1,128 | 158 |
| Sector | Health Care | Health Care |
| Industry | Medicinal Chemicals and Botanical Products | Biotechnology: In Vitro & In Vivo Diagnostic Substances |
Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.
Key differences
- TKNO has outperformed CGC by 105.8 percentage points over the past year.
About Canopy Growth
CGC stock →Canopy Growth Corporation, together with its subsidiaries, engages in the production, distribution, and sale of cannabis and cannabis-related products for medical and adult use in Canada, Germany, the United States, and internationally. The company operates through two segments, Cannabis and Storz & Bickel.
Health Care · Medicinal Chemicals and Botanical Products · 1,128 employees
About Alpha Teknova
TKNO stock →Alpha Teknova, Inc. produces critical reagents for the discovery, development, and commercialization of novel therapies, vaccines, and molecular diagnostics in the United States and internationally.
Health Care · Biotechnology: In Vitro & In Vivo Diagnostic Substances · 158 employees
CGC vs TKNO FAQ
Which is bigger, Canopy Growth or Alpha Teknova?
Alpha Teknova (TKNO) is larger, with a market capitalization of $467.62M compared with $393.81M for Canopy Growth (CGC).
Which stock has performed better over the past year, CGC or TKNO?
TKNO returned +66.22% over the past 12 months, compared with -39.55% for CGC (price return, excluding dividends). Past performance does not predict future results.
Are Canopy Growth and Alpha Teknova in the same industry?
Both are in the Health Care sector, but in different industries: Medicinal Chemicals and Botanical Products for Canopy Growth and Biotechnology: In Vitro & In Vivo Diagnostic Substances for Alpha Teknova.